(Bloomberg) China’s once-mighty shoppers have turned into reluctant spenders in the face of an economic slowdown, a shift that’s proving particularly painful for stocks related to premium brands.Most Read from BloombergSouthwest Plane Plunged Within 400 Feet of Ocean Near HawaiiWells Fargo Fires Over a Dozen for ‘Simulation of Keyboard Activity’Yes, Everyone Really Is Sick a Lot More Often After CovidBump Stock Ban Tossed Out by Supreme Court in Gun-Rights WinTesla Investors Get Behind Musk’s
National Bank Deal at 'Hefty Premium' to Test Investor Patience financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.
Jefferies Financial Group (NYSE:JEF – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Wednesday. Separately, Oppenheimer increased their price objective on shares of Jefferies Financial Group from $54.00 to $56.00 and gave the stock an “outperform” rating in a report […]
Equities Research Analysts’ updated eps estimates for Thursday, June 13th: ADENTRA (TSE:ADEN) was given a C$51.00 price target by analysts at Scotiabank. The firm currently has an outperform rating on the stock. ADENTRA (TSE:ADEN) had its price target increased by National Bankshares, Inc. from C$51.50 to C$53.00. They currently have an outperform rating on the […]
Investment Analysts’ updated eps estimates for Wednesday, June 12th: Bionomics (NASDAQ:BNOX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $8.00 price target on the stock. BioRestorative Therapies (NASDAQ:BRTX) had its buy rating reaffirmed by analysts at Roth Mkm. Roth Mkm currently has a $15.00 price target on the stock. […]